The study asses how effective bhringraj yog is in managing urdhwaga amlapitta which corresponds to gastroesophageal reflux disease.

A study to evaluate the efficacy of Bhringraj yog in the management of Urdhwag amlapitta an open randomised controlled clinical trial W.S.R. to Gastroesophageal Reflux Disease - Nill

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085499

Enrollment

Registered

2025-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient having symptoms of Urdhwag Amlapitta like tikta Amloudgar, aruchi , Shirshul, Hritkanth daha, Chardi

Exclusion criteria

Exclusion criteria: 1. Patient below 16 yrs and above 60 yrs will be excluded 2. Pregnant and lactating women. 3. Patient having chronic diseases like Diabetis mellitus with complication, and chronic kidney diseases, Alcoholic liver Cirrhosis, Hypertension.

Design outcomes

Primary

Measure	Time frame
Bhringraj yog is effective in the management of urdhwaga amlapittaTimepoint: Initial assessment at 0 day ollow up at 10th,20th day Final assessment at 30th day	—

Secondary

Measure	Time frame
Bhringraj yog is more effective than Avipattikar churna vati in the management of Urdhwaga amlapittaTimepoint: Initial assessment at 0 day ollow up at 10th,20th day Final assessment at 30th day	—

Countries

India

Contacts

Public ContactDr Satgonda B Patil

Late Kedari Redekar Ayurvedic Mahavidylaya, Gadhinglaj, Kolhapur. 416502

dr.jayantpatil07@gmail.com8600660485

Outcome results